Author:
Yatabe Yasushi,Dacic Sanja,Borczuk Alain C.,Warth Arne,Russell Prudence A.,Lantuejoul Sylvie,Beasley Mary Beth,Thunnissen Erik,Pelosi Giuseppe,Rekhtman Natasha,Bubendorf Lukas,Mino-Kenudson Mari,Yoshida Akihiko,Geisinger Kim R.,Noguchi Masayuki,Chirieac Lucian R.,Bolting Johan,Chung Jin-Haeng,Chou Teh-Ying,Chen Gang,Poleri Claudia,Lopez-Rios Fernando,Papotti Mauro,Sholl Lynette M.,Roden Anja C.,Travis William D.,Hirsch Fred R.,Kerr Keith M.,Tsao Ming-Sound,Nicholson Andrew G.,Wistuba Ignacio,Moreira Andre L.
Funder
Japanese Society for the Promotion of Science
National Cancer Institute
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference207 articles.
1. The 2015 World Health Organization Classification of Lung Tumors: impact of genetic, clinical and radiologic advances since the 2004 classification;Travis;J Thorac Oncol,2015
2. IASLC Atlas of ALK and ROS1 Testing in Lung Cancer,2017
3. IASLC Atlas of PD-L1 Testing in Lung Cancer,2016
4. Various antibody clones of napsin A, thyroid transcription factor 1, and p40 and comparisons with cytokeratin 5 and p63 in histopathologic diagnostics of non-small cell lung carcinoma;Tran;Appl Immunohistochem Mol Morphol,2016
5. Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung;Whithaus;Arch Pathol Lab Med,2012